Investor Relations & Capital Introduction in Incheon

Incheon is South Korea's main international gateway and a fast-growing centre of biotechnology, logistics and international business. For founders in biopharmaceuticals, logistics and green technology, it offers a free economic zone, a world-class airport and direct access to Seoul.

Why Incheon Matters for Capital Raising

Incheon International Airport, opened in 2001, is one of the world's leading air hubs and cargo gateways, and the city's port is one of Korea's largest.

The Songdo district, part of the Incheon Free Economic Zone, is home to Samsung Biologics, founded in 2011, and Celltrion, making it one of the world's largest centres of biopharmaceutical manufacturing.

Songdo also hosts the headquarters of the Green Climate Fund and several international university campuses.

What Incheon Investors Examine

For biotechnology businesses, manufacturing partnerships and regulatory pathways are examined closely.

Investors value capital efficiency and plans to scale across Korea and Asia.

Engagement and Access

GCN connects founders with Incheon corporate investors, biotech funds and the Seoul investor community through conference programming and private sessions across Korea and internationally.

Sectors where we see consistent Incheon interest include biopharmaceuticals, logistics and aviation, green technology, smart cities and education.

Partner with Global Capital Network

Whether you are raising into Incheon or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.